Trimethadione
From Wikipedia, the free encyclopedia
 |
|
|
Trimethadione
|
|
| Systematic (IUPAC) name | |
| 3,5,5-trimethyloxazolidine-2,4-dione | |
| Identifiers | |
| CAS number | 127-48-0 |
| ATC code | N03AC02 |
| PubChem | 5576 |
| DrugBank | APRD00315 |
| Chemical data | |
| Formula | C6H9NO3 |
| Mol. weight | 143.141 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
℞ Prescription only |
| Routes | ? |
Trimethadione is an oxazolidinedione anticonvulsant. It is used to treat epileptic conditions that are resistant to other treatments.
It can be associated with fetal trimethadione syndrome.
[edit] External links
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
